Samples for study ST002976
Species: BALB/C nude mice (Factor headings shown in green)mb_sample_id | Subject name | Sample name | Treatment | Sample_Data:RAW_FILE_NAME |
---|---|---|---|---|
SA323226 | - | 2A1-01-10477 | 5-fluorouracil | 2A1-01-10477.d |
SA323228 | - | 2A1-02-10478 | 5-fluorouracil | 2A1-02-10478.d |
SA323221 | - | 2A2-01-10479 | 5-fluorouracil | 2A2-01-10479.d |
SA323220 | - | 2A2-02-10480 | 5-fluorouracil | 2A2-02-10480.d |
SA323219 | - | 2B1-01-10481 | 5-fluorouracil | 2B1-01-10481.d |
SA323222 | - | 2B1-02-10482 | 5-fluorouracil | 2B1-02-10482.d |
SA323227 | - | 2B2-01-10483 | 5-fluorouracil | 2B2-01-10483.d |
SA323223 | - | 2B2-02-10484 | 5-fluorouracil | 2B2-02-10484.d |
SA323225 | - | 2B3-01-10485 | 5-fluorouracil | 2B3-01-10485.d |
SA323224 | - | 2B3-02-10486 | 5-fluorouracil | 2B3-02-10486.d |
SA323232 | - | 1A1-01-10464 | Doxorubicin | 1A1-01-10464.d |
SA323233 | - | 1A1-02-10465 | Doxorubicin | 1A1-02-10465.d |
SA323231 | - | 1A2-01-10466 | Doxorubicin | 1A2-01-10466.d |
SA323229 | - | 1A2-02-10467 | Doxorubicin | 1A2-02-10467.d |
SA323230 | - | 1A3-01-10468 | Doxorubicin | 1A3-01-10468.d |
SA323235 | - | 1A3-02-10469 | Doxorubicin | 1A3-02-10469.d |
SA323237 | - | 1B1-01-10470 | Doxorubicin | 1B1-01-10470.d |
SA323239 | - | 1B1-02-10471 | Doxorubicin | 1B1-02-10471.d |
SA323240 | - | 1B2-01-10472 | Doxorubicin | 1B2-01-10472.d |
SA323238 | - | 1B2-02-10473 | Doxorubicin | 1B2-02-10473.d |
SA323236 | - | 1B3-01-10474 | Doxorubicin | 1B3-01-10474.d |
SA323234 | - | 1B3-02-10475 | Doxorubicin | 1B3-02-10475.d |
SA323245 | - | 3A1-01-10488 | Doxorubicin + 5-fluorouracil | 3A1-01-10488.d |
SA323248 | - | 3A1-02-10489 | Doxorubicin + 5-fluorouracil | 3A1-02-10489.d |
SA323247 | - | 3A2-01-10490 | Doxorubicin + 5-fluorouracil | 3A2-01-10490.d |
SA323249 | - | 3A2-02-10491 | Doxorubicin + 5-fluorouracil | 3A2-02-10491.d |
SA323250 | - | 3B1-01-10492 | Doxorubicin + 5-fluorouracil | 3B1-01-10492.d |
SA323246 | - | 3B1-02-10493 | Doxorubicin + 5-fluorouracil | 3B1-02-10493.d |
SA323243 | - | 3B2-01-10494 | Doxorubicin + 5-fluorouracil | 3B2-01-10494.d |
SA323241 | - | 3B2-02-10495 | Doxorubicin + 5-fluorouracil | 3B2-02-10495.d |
SA323242 | - | 3B3-01-10496 | Doxorubicin + 5-fluorouracil | 3B3-01-10496.d |
SA323244 | - | 3B3-02-10497 | Doxorubicin + 5-fluorouracil | 3B3-02-10497.d |
SA323258 | - | 4A1-01-10499 | Positive Control | 4A1-01-10499.d |
SA323257 | - | 4A1-02-10500 | Positive Control | 4A1-02-10500.d |
SA323259 | - | 4A2-01-10501 | Positive Control | 4A2-01-10501.d |
SA323260 | - | 4A2-02-10502 | Positive Control | 4A2-02-10502.d |
SA323256 | - | 4A4-01-10503 | Positive Control | 4A4-01-10503.d |
SA323261 | - | 4A4-02-10504 | Positive Control | 4A4-02-10504.d |
SA323262 | - | 4B1-01-10505 | Positive Control | 4B1-01-10505.d |
SA323254 | - | 4B1-02-10506 | Positive Control | 4B1-02-10506.d |
SA323251 | - | 4B2-01-10507 | Positive Control | 4B2-01-10507.d |
SA323252 | - | 4B2-02-10508 | Positive Control | 4B2-02-10508.d |
SA323253 | - | 4B3-01-10509 | Positive Control | 4B3-01-10509.d |
SA323255 | - | 4B3-02-10510 | Positive Control | 4B3-02-10510.d |